Treatment Effects of Xuebijing Injection in Severe Septic Patients with Disseminated Intravascular Coagulation
Authors:
Open Access
- 1 January 2014
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2014 (1) , 949254
Abstract
The treatment effects of Xuebijing (XBJ) injection in severe septic patients with disseminated intravascular coagulation (DIC) were investigated in this study. 171 severe septic patients with DIC were divided into the control group (n = 83) or intervention group (n = 88). Routine therapies were administered in both groups, and XBJ injection was administered additionally in the intervention group. Incidence of DIC, clinical severity scores, and coagulation parameters at 7 days after administration of XBJ injection were compared between the two groups, and short‐term prognosis was evaluated by 28‐day mortality. Compared with the control group, incidence of DIC in the intervention group was significantly lower at 7 days after administration of XBJ injection (P < 0.001). In addition, differences of platelet count and prothrombin time were significantly greater in the intervention group than in the control group (P all P all P = 0.034). These results demonstrate that XBJ injection can effectively treat DIC caused by severe sepsis and improve short‐term prognosis of severe septic patients with DIC.Keywords
This publication has 23 references indexed in Scilit:
- Identification of the major constituents in Xuebijing injection by HPLC‐ESI‐MSPhytochemical Analysis, 2011
- Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: Results of a multicenter, prospective survey*Critical Care Medicine, 2008
- Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital—Meaning of the ISTH score system, fibrin monomers, and lipoprotein–C-reactive protein complex formationAmerican Journal of Hematology, 2006
- Treatment effects of high‐dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulationJournal of Thrombosis and Haemostasis, 2006
- Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulationJournal of Thrombosis and Haemostasis, 2004
- Hemostatic markers and the sepsis‐related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unitAmerican Journal of Hematology, 2004
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceCritical Care Medicine, 2003
- Mortality in Emergency Department Sepsis (MEDS) score: A prospectively derived and validated clinical prediction rule*Critical Care Medicine, 2003
- Disseminated Intravascular CoagulationNew England Journal of Medicine, 1999
- APACHE IICritical Care Medicine, 1985